NANŌMIX

Nanōmix was founded in 2000 by UC Berkeley professors and award-winning physicists at Lawrence Berkeley National Laboratory, Marvin L. Cohen and Alex Zettl. Today, our company is poised to become the premier provider of the next generation of rapid point-of-care diagnostics. The POC testing market is currently valued at approximately $20 billion... Nanōmix Corporation announced a new distribution agreement with Diaclinic SpA, a medical distributor headquartered in Santiago, Chile. Diaclinic will market and distribute the Nanōmix eLab in the Republic of Chile... In 2017, Nanōmix formed a collaboration with World Technology East 2, RedPharm Biotechnology Ltd, and associated entities in Hong Kong, China, and the European Community. Our partnership focuses on the use and deployment of Nanomix products and technology throughout Asia for human applications and worldwide veterinary applications in farm animal, companion animal, and wildlife management and control.

Also known as: Nanōmix, Inc.

Primary location: Chile